2Lae M, Couturier J, Oudard S,et al. Assessing HER2 gene amplication as a potential target for therapy in invasive urothelial bladder cancer With a standardized methodology: results in 1005 patients [J]. AnnOncol, 2010, 21(4): 815-819. 被引量：1
6Latif Z, Watters AD, Dunn I,et al. HER2/neu gene amplication and protein overexpression in G3 pT2 transitional cell earcinoma of the bladder: a role for anti-HER2 therapy? [ J]. Eur J Cancer, 2004,40( 1 ) :56-63. 被引量：1
7de Pinieux G, Colin D, Vincent-Salomon A,et al. Confrontation of irnmunohistochernistry and fluorescent in situ hybridization for the assessment of HER-2/neu (c-erbb-2) status in urothelial carcinoma [J]. Virchows Arch ,2004,444 ( 5 ) :415-419. 被引量：1
8Simonetti S, Russo R, Ciancia G,et al. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erhB-2 gene and chromosome 17 [J]. Int J Surg Pathol, 2009, 17 (5): 198-205. 被引量：1
10Zhau HE, Zhang X, yon Eschenbaeh AC, et al. Amplification and expression of the e-erb B-2/neu proto-oneogene in human bladder eaneer[ J]. Mol Careinog, 1990,3 (5) :254-257. 被引量：1
8LARSSON P,WIJKSTROM H,THORSTENSON A, et al. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years [J]. Scand J Urol Nephrol, 2003, 37:195-201. 被引量：1
9LATIF Z, WATTERS AD, DUNN I, et al. HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder[J]. Br J Cancer, 2003, 89(7): 1305-1309. 被引量：1
10LATIF Z, WATTERS AD, DUNN I, et al. HER2/neu gene amplification and protein overexpression in G3 pT2 transtionalcell carcinoma of the bladder: a role for anti-HER2 therapy?[J]. Eur J Cancer, 2004, 40(1):56-63. 被引量：1
6Christopher L Coogan,Carlos R Estrada,Shiv Kapur,Kenneth J Bloom.HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder[J].Urology.2004(4) 被引量：2
7EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update[J]. European Urology . 2011 (6) 被引量：3
8Gregory T. MacLennan,Ziya Kirkali,Liang Cheng.??Histologic Grading of Noninvasive Papillary Urothelial Neoplasms(J)European Urology . 2006 (4) 被引量：1
9Richard J. Sylvester,Adrian P.M. van der Meijden,Willem Oosterlinck,J. Alfred Witjes,Christian Bouffioux,Louis Denis,Donald W.W. Newling,Karlheinz Kurth.??Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials <ce:link locator='fx1'/>(J)European Urology . 2006 (3) 被引量：2
10Sato K,Moriyama M,Mori S,et al.An immunohistologic evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer . 1992 被引量：1
